We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+3.67%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$5.09B
AUM Growth
-$12.9M
(-0.25%)
Cap. Flow
-$125M
Cap. Flow
% of AUM
-2.45%
Top 10 Holdings %
Top 10 Hldgs %
24.56%
Holding
226
New
31
Increased
59
Reduced
73
Closed
26
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$30.5M |
| 2 |
Merck
MRK
|
+$25.8M |
| 3 |
Mine Safety
MSA
|
+$17.2M |
| 4 |
First Horizon
FHN
|
+$16.9M |
| 5 |
Western Alliance Bancorporation
WAL
|
+$15.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$38.3M |
| 2 |
NetEase
NTES
|
+$36.1M |
| 3 |
SBNY
Signature Bank
SBNY
|
+$35.9M |
| 4 |
JOBS
51job Inc
JOBS
|
+$29.3M |
| 5 |
EV
Eaton Vance Corp.
EV
|
+$27.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 18.64% |
| 2 | Financials | 17.22% |
| 3 | Technology | 14.65% |
| 4 | Healthcare | 14.45% |
| 5 | Industrials | 13.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Editas Medicine
EDIT
$436M
| $4.3M | 0.08% |
+120,000
| New | +$4.25M |
|
152
Expedia Group
EXPE
$39.1B
| $4.21M | 0.08% |
35,000
-25,000
| -42% | -$2.89M |
|
153
Weibo
WB
$1.91B
| $3.9M | 0.08% |
44,000
+5,000
| +13% | +$544K |
|
154
Sarepta Therapeutics
SRPT
$1.94B
| $3.9M | 0.08% |
29,500
-4,000
| -12% | -$377K |
|
|
ABMD
155
DELISTED
Abiomed Inc
ABMD
| $3.89M | 0.08% |
9,500
-8,000
| -46% | -$2.9M |
|
|
ARQL
156
DELISTED
Arqule Inc
ARQL
| $3.87M | 0.08% |
+700,000
| New | +$2.67M |
|
157
Bristol-Myers Squibb
BMY
$130B
| $3.66M | 0.07% |
66,060
-30,000
| -31% | -$1.62M |
|
158
United Natural Foods
UNFI
$2.9B
| $3.63M | 0.07% |
+85,000
| New | +$3.75M |
|
159
Tesla
TSLA
$1.29T
| $3.53M | 0.07% |
154,410
| – | – |
|
160
Itaú Unibanco
ITUB
$81.6B
| $3.44M | 0.07% |
682,637
-249,440
| -27% | -$1.55M |
|
161
Global Water Resources
GWRS
$219M
| $3.41M | 0.07% |
362,648
+7,265
| +2% | +$66.4K |
|
162
Badger Meter
BMI
$3.91B
| $3.35M | 0.07% |
75,000
-35,000
| -32% | -$1.55M |
|
163
Deere & Co
DE
$167B
| $3.21M | 0.06% |
+23,000
| New | +$3.39M |
|
|
WAAS
164
DELISTED
AquaVenture Holdings Limited
WAAS
| $2.98M | 0.06% |
+190,982
| New | +$2.74M |
|
165
Amgen
AMGN
$225B
| $2.76M | 0.05% |
14,940
-5,000
| -25% | -$884K |
|
|
MYOK
166
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $2.63M | 0.05% |
53,000
+20,000
| +61% | +$968K |
|
167
Teladoc Health
TDOC
$1.22B
| $2.61M | 0.05% |
+45,000
| New | +$2.2M |
|
|
WUBA
168
DELISTED
58.com Inc
WUBA
| $2.54M | 0.05% |
36,700
| – | – |
|
|
HTT
169
High Templar Tech Ltd
HTT
$391M
| $2.39M | 0.05% |
+270,000
| New | +$2.71M |
|
170
Galicia Financial Group
GGAL
$7.1B
| $2.18M | 0.04% |
66,152
| – | – |
|
|
JKS
171
JinkoSolar
JKS
$860M
| $2.16M | 0.04% |
156,844
-30,000
| -16% | -$509K |
|
|
FOMX
172
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $1.95M | 0.04% |
390,000
+25,500
| +7% | +$131K |
|
173
Trip.com Group
TCOM
$28.7B
| $1.81M | 0.04% |
38,000
| – | – |
|
|
JOYY
174
JOYY Inc
JOYY
$3.74B
| $1.78M | 0.03% |
17,700
| – | – |
|
175
General Mills
GIS
$20.4B
| $1.77M | 0.03% |
40,000
-219,122
| -85% | -$9.59M |
|
Similar funds
VIA
Handelsbanken Fonder's Q2 2018 Portfolio in Review
As of Q2 2018, Handelsbanken Fonder held 226 positions worth $5.09B, down 0.25% from $5.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Handelsbanken Fonder's Q2 2018 filing shows 31 new, 59 increased, 73 reduced and 26 closed positions. Its largest new stake was Mine Safety: 190,000 shares worth $18.3M. The largest sale was Alibaba, an estimated $38.3M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 19% a quarter earlier, followed by Financials and Technology.
- Handelsbanken Fonder's largest Q2 2018 buy was Mine Safety: 190,000 shares worth $18.3M.
- Handelsbanken Fonder added most to Thermo Fisher Scientific in Q2 2018, an estimated $30.5M increase.
- Handelsbanken Fonder's biggest Q2 2018 reduction was Alibaba, cutting an estimated $38.3M.
- Handelsbanken Fonder fully exited Eaton Vance Corp. in Q2 2018, selling an estimated $27.8M.
- Handelsbanken Fonder's ten largest holdings make up 25% of its $5.09B portfolio in Q2 2018.
- Handelsbanken Fonder opened 31 new positions and closed 26 in Q2 2018.
- Handelsbanken Fonder's portfolio value fell 0.25% quarter-over-quarter to $5.09B.
Based on Handelsbanken Fonder's 13F filing for Q2 2018, filed 11 Jul 2018.